Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Novozymes TEDA Biopharma Facility on Track for Early 2011 Opening

publication date: Apr 13, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Novozymes, the Danish manufacturer of enzymes, said its first biopharmaceutical manufacturing facility in China will be ready for operation in Q1 of 2011. The facility, which began construction a year ago, is being built in the Tianjin Economic-Technological Development Area (TEDA) at a cost of between $35 million and $50 million. More details...

Stock Symbol: (OTCPK: NVZMF; Copenhagen A/S: NZYM B)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners